STEER was a retrospective, observational real-world study, evaluating the efficacy of semaglutide 2.4 mg versus tirzepatide for the prevention of MACE in US adults with overweight or obesity and established CVD with no prior history of diabetes, with a primary outcome measure of revised 5-point MACE (heart attack, stroke, hospitalisation for heart failure, coronary revascularisation, and death from any cause) and revised 3-point MACE (heart attack, stroke and death from any cause)
How many mg is 10 units of semaglutide
The 2022 American Society for Metabolic and Bariatric Surgery and International Federation for Surgery and Other Therapies for Obesity guidelines 29 recommend metabolic-bariatric surgery for patients with MASLD or MASH whose body mass index is 30 kg/m 2 or higher who do not achieve substantial weight loss with nonsurgical methods
Available from: Medicare Coverage of Anti-Obesity Medications [Internet]
doi: 10.1210/jcemcr/luac017 47 TanXPanXWuXZhengSChenYLiuDet al
Not all fibers act the same in our digestive tracts or have the same health benefits
